A Randomized Double-blind Placebo-controlled Phase 3 Study to Evaluate the Effect of Resmetirom on Liver-related Outcomes in Patients with Well-compensated (Child-Pugh A) Non-alcoholic Steatohepatitis (NASH) Cirrhosis

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Nonalcoholic Steatohepatitis (nash)
  • Age: Between 18 Year(s) - 100 Year(s)
  • Gender: Male or Female
  • Other Inclusion Criteria:
    1. Must be willing to participate in the study and provide written informed consent
    2. Male and female adults =18 years of age
    3. Clinical diagnosis of NASH Cirrhosis
    4. Female patients who:
      a) are of reproductive pot

You may not be eligible for this study if the following are true:

    1. Chronic liver diseases other than NASH cirrhosis:
      a) Primary biliary cholangitis
      b)Primary sclerosing cholangitis
      c) Hepatitis B positive
      d) Hepatitis C
      e) History or evidence of current active autoimmune hepatitis



If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.